Skip to Content

Research

  Modified Citrus Pectin Slows PSA Doubling Time: A Pilot Clinical Trial

  Fighting Cancer Metastasis and Heavy Metal Toxicities With Modified Citrus Pectin

  Clinical Benefit in Patients with Advanced Solid Tumors Treated with Modified Citrus Pectin: A Prospective Pilot Study

  Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study

  Inhibitory effect of modified citrus pectin on liver metastases in a mouse colon cancer model

  Modified Citrus Pectin Induces Cytotoxicity Of Prostate Cancer Cells In Cocultures With Human Endothelial Monolayers

  Modified Citrus Pectin Decreases the Total Body Burden of Mercury: A Pilot Human Clinical Trial

  Integrative Medicine and the Role of Modified Citrus Pectin/Alginates in Heavy Metal Chelation and Detoxification – Five Case Reports

  The Effect of Modified Citrus Pectin on Urinary Excretion of Toxic Elements

  The Role Of Modified Citrus Pectin As An Effective Chelator Of Lead In Children Hospitalized With Toxic Lead Levels